Status:
COMPLETED
Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
Lead Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions:
Immune Thrombocytopenic Purpura
Eligibility:
All Genders
18+ years
Brief Summary
Symptoms of Primary Immune Thrombocytopenic Purpura (pITP), such as spontaneous bruising, menorrhagia, mucosal bleeding and other symptoms might significantly affect the HRQOL of pITP patients. Howeve...
Detailed Description
OBJECTIVES: The primary objective is to compare HRQOL of patients with pITP with that of a matched Italian population control Group. Secondary objectives include evaluation of: * Patient-reported f...
Eligibility Criteria
Inclusion
- A confirmed diagnosis of pITP in any phase of the disease;
- Patients aged at least 18 years;
- Informed consent provided
Exclusion
- Participating in other HRQOL investigations that might interfere with this study
- Having any psychiatric condition or major cognitive impairment hampering self-reported HRQOL evaluation.
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
424 Patients enrolled
Trial Details
Trial ID
NCT01510873
Start Date
December 1 2011
End Date
January 1 2014
Last Update
January 23 2014
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza
San Giovanni Rotondo, Foggia, Italy
2
Ospedale Generale Regionale "F. Miulli"
Acquaviva delle Fonti, Italy
3
Azienda Ospedaliero-Universitaria Policlinico Consorziale
Bari, Italy
4
Azienda Sanitaria Locale BA - Ospedale di Venere
Bari, Italy